Fact CheckerSign in

NCT05235633Enrolling by invitation

ADLs at the End of Acute Treatment for Childhood Leukemia and Non-Hodgkin Lymphoma

Activities of Daily Living at the End of Acute Treatment for Acute Leukemia or Non-Hodgkin Lymphona During Childhood and Adolescence

Source: ClinicalTrials.gov · Last updated 19 Aug 2026

Brief summary (registry, in English)

Reduced activity levels and reduced muscular strength could severely impair the activities of daily living (ADLs) in pediatric leukemia and Non-Hodgkin lymphoma patients. Increased muscle strength is associated with improved accomplishment of ADLs and consequently greatest possible normality, autonomy and mobility. This associated investigation to the study with the ClinicalTrials.gov Identifier NCT03934060 aims at collecting data in a comparison cohort with respect to ADLs in children and adolescents who did not receive a standardized strenght training intervention during the whole course of treatment.

Status (registry)
Enrolling by invitation
Study type
Observational
Enrollment
20 (estimated)
First submitted
11 Jan 2022
Start date
19 Apr 2022
Primary completion date
31 Jul 2027
Lead sponsor
Technical University of Munich
NCT number
NCT05235633

What you commit to

  • Study type: Observational
  • Planned participants: 20
  • From 19 Apr 2022 to the primary completion date, 31 Jul 2027
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other illness

  • Medical contraindication to perform this unique test battery (e.g., acute bleeding risk, pain, nausea, acute orthopedic impairments)

Other

  • Inability to follow study procedures (e.g., language problems, mental retardation)

Who the study is looking for

  • Children and adolescents aged 4-18 years
  • At the end of acute treament for leukemia or non-Hodgkin lymphoma
  • Diagnosed and/or treated at the Dr. von Hauner Children's Hospital, University of Munich
  • Informed consent as documented by signature

Age in the registry: 4 years to 18 years · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Kinderklinik München Schwabing, TUM School of Medicine, Department of Paediatrics and Children's Cancer Research Center, Technical University of Munich, Germany
Coordinator of this site? Confirm its status
MunichGermanyUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.